Assessment of liver tumor response to therapy: role of quantitative imaging.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Radiographics

• Publication date

  2013-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1148/rg.336135511PMID 24108562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diffusion-weighted MR imaging in liver metastases of colorectal cancer: reproducibility and biological validation

  2013cited by this paper
• Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.

  2013cited by this paper
• CT perfusion in oncologic imaging: a useful tool?

  2013cited by this paper
• Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma.

  2013cited by this paper
• mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE).

  2013cited by this paper
• Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma

  2012cited by this paper
• Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response.

  2012cited by this paper
• Hepatic tumors: region-of-interest versus volumetric analysis for quantification of attenuation at CT.

  2012cited by this paper
• Comparison of response evaluation criteria in solid tumors with volumetric measurements for estimation of tumor burden in pancreatic adenocarcinoma and hepatocellular carcinoma.

  2012cited by this paper
• Evaluation of the mRECIST and α-Fetoprotein Ratio for Stratification of the Prognosis of Advanced-Hepatocellular-Carcinoma Patients Treated with Sorafenib

  2012cited by this paper
• Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria.

  2012cited by this paper
• Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity.

  2012cited by this paper
• Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization.

  2012cited by this paper
• Neuroendocrine tumor liver metastases: use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response.

  2012cited by this paper
• Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models.

  2012cited by this paper
• Review of MR elastography applications and recent developments

  2012cited by this paper
• Prediction of growth rate of solid renal masses: utility of MR imaging features--preliminary experience.

  2012cited by this paper
• Diffusion-weighted MR imaging for the regional characterization of liver tumors.

  2012cited by this paper
• Reproducibility of CT perfusion parameters in liver tumors and normal liver.

  2011cited by this paper
• MDCT evaluation of the growth kinetics of serous and benign mucinous cystic neoplasms of the pancreas

  2011cited by this paper
• Novel oncologic drugs: what they do and how they affect images.

  2011cited by this paper
• Liver Metastases From Colorectal Cancer Treated With Conventional and Antiangiogenetic Chemotherapy: Evaluation With Liver Computed Tomography Perfusion and Magnetic Resonance Diffusion-Weighted Imaging

  2011cited by this paper
• EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization.

  2011cited by this paper
• Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.

  2011cited by this paper
• Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.

  2011cited by this paper
• 18F‐fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma

  2011cited by this paper
• Diffusion MR imaging for monitoring of treatment response.

  2011cited by this paper
• Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.

  2011cited by this paper
• Evaluation of hepatocellular carcinoma size using two-dimensional and volumetric analysis: effect on liver transplantation eligibility.

  2011cited by this paper
• Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0.

  2011cited by this paper
• Does multidetector CT attenuation change in colon cancer liver metastases treated with 90Y help predict metabolic activity at FDG PET?

  2010cited by this paper
• Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version)

  2010cited by this paper
• Treatment Planning and Volumetric Response Assessment for Yttrium-90 Radioembolization: Semiautomated Determination of Liver Volume and Volume of Tumor Necrosis in Patients with Hepatic Malignancy

  2010cited by this paper
• Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging.

  2010cited by this paper
• Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

  2010cited by this paper
• Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.

  2010cited by this paper
• RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline

  2009cited by this paper
• Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib

  2009cited by this paper
• Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

  2009cited by this paper
• Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results.

  2009cited by this paper
• MR spectroscopy of the liver: principles and clinical applications.

  2009cited by this paper
• New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

  2009cited by this paper
• Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.

  2009cited by this paper
• Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma

  2009cited by this paper
• From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

  2009cited by this paper
• Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate?

  2009cited by this paper
• Radiologic measurements of tumor response to treatment: practical approaches and limitations.

  2008cited by this paper
• Sorafenib in advanced hepatocellular carcinoma.

  2008cited by this paper
• Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay.

  2008cited by this paper
• Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases.

  2008cited by this paper
• Spectrum of CT findings after radiofrequency ablation of hepatic tumors.

  2008cited by this paper
• Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.

  2008cited by this paper
• Molecular targeted therapies in hepatocellular carcinoma

  2008cited by this paper
• Review of phase II trial designs used in studies of molecular targeted agents: outcomes and predictors of success in phase III.

  2008cited by this paper
• Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.

  2007cited by this paper
• Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

  2007cited by this paper
• Consensus and controversy in the management of hepatocellular carcinoma.

  2007cited by this paper
• Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.

  2007cited by this paper
• Positron emission tomography for staging and assessment of tumor response of hepatic malignancies.

  2006cited by this paper
• In vivo 1H magnetic resonance spectroscopy in evaluation of hepatocellular carcinoma and its early response to transcatheter arterial chemoembolization.

  2006cited by this paper
• Imaging response assessment in oncology

  2006cited by this paper
• Viscoelastic shear properties of in vivo breast lesions measured by MR elastography.

  2005cited by this paper
• Monitoring stiffness changes in lesions after radiofrequency ablation at different temperatures and durations of ablation.

  2005cited by this paper
• A theoretical approach to choosing the minimum number of multiple tumors required for assessing treatment response.

  2005cited by this paper
• In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0‐T MR scanner

  2004cited by this paper
• CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings.

  2004cited by this paper
• Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma.

  2003cited by this paper
• CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations.

  2002cited by this paper
• Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT.

  2001cited by this paper
• Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

  2001cited by this paper
• Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

  2001cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size.

  2000cited by this paper
• Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma.

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors

  2000cited by this paper
• Magnetic resonance elastography by direct visualization of propagating acoustic strain waves.

  1995cited by this paper
• WHO Handbook for Reporting Results of Cancer Treatment

  1980cited by this paper

• Treatments and cancer: implications for radiologists

  2025cites this paper
• Potential of Radiomics, Dosiomics, and Dose Volume Histograms for Tumor Response Prediction in Hepatocellular Carcinoma following 90Y-SIRT

  2025cites this paper
• From Imaging to Impact: A Multi-Disciplinary T32 Program Framework and Initial Insights for Training in Image-Guided Cancer Therapy [Advance Publication]

  2025cites this paper
• Evaluating the Efficacy of Deep Learning Reconstruction in Reducing Radiation Dose for Computer-Aided Volumetry for Liver Tumor: A Phantom Study

  2024cites this paper
• The role of biomarkers and dosimetry parameters in overall and progression free survival prediction for patients treated with personalized 90Y glass microspheres SIRT: a preliminary machine learning study

  2024cites this paper
• Comparison of automated with manual 3D qEASL assessment based on MR imaging in hepatocellular carcinoma treated with conventional TACE

  2024cites this paper
• Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy: an evaluation of volumetric imaging parameters

  2024cites this paper
• Voxel-Based Dosimetry Predicts Local Tumor Progression Post 90Y Radiation Segmentectomy of Colorectal Liver Metastases

  2024cites this paper
• Edge-aware Multi-task Network for Integrating Quantification Segmentation and Uncertainty Prediction of Liver Tumor on Multi-modality Non-contrast MRI

  2023cites this paper
• Maximum tumor-absorbed dose measured by voxel-based multicompartmental dosimetry as a response predictor in yttrium-90 radiation segmentectomy for hepatocellular carcinoma

  2023cites this paper
• Assessment of the response to systemic treatment of colorectal liver metastases on cross-sectional imaging – a systematic review

  2023cites this paper
• Follow-up of liver metastases: a comparison of deep learning and RECIST 1.1

  2023cites this paper
• Comparison of quantitative volumetric analysis and linear measurement for predicting the survival of Barcelona Clinic Liver Cancer 0- and A stage hepatocellular carcinoma after radiofrequency ablation

  2023cites this paper
• Techniques and Algorithms for Hepatic Vessel Skeletonization in Medical Images: A Survey

  2022cites this paper
• Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas

  2022cites this paper
• Local-Regional Treatment of Hepatocellular Carcinoma: A Primer for Radiologists.

  2022cites this paper
• Three-Dimensional Quantitative Tumor Response and Survival Analysis of Hepatocellular Carcinoma Patients Who Failed Initial Transarterial Chemoembolization: Repeat or Switch Treatment?

  2022cites this paper
• Task relevance driven adversarial learning for simultaneous detection, size grading, and quantification of hepatocellular carcinoma via integrating multi-modality MRI

  2022cites this paper
• RECIST 1.1 versus mRECIST for assessment of tumour response to molecular targeted therapies and disease outcomes in patients with hepatocellular carcinoma: a systematic review and meta-analysis

  2022cites this paper
• Leitliniengerechte Anwendung der Thermoablation beim hepatozellulären Karzinom

  2022cites this paper
• Colorectal liver metastases: ADC as an imaging biomarker of tumor behavior and therapeutic response.

  2021cites this paper
• Abdominal Imaging

  2021cites this paper
• Liver fibrosis promotes immunity escape but limits the size of liver tumor in a rat orthotopic transplantation model

  2021cites this paper
• Quantification of Tc-99m macroaggregated albumin liver perfusion as a predictor of tumor response to intra-arterial therapy with yttrium 90 spheres

  2021cites this paper
• Molecular Imaging of Tumor Microenvironment to Assess the Effects of Locoregional Treatment for Hepatocellular Carcinoma

  2021cites this paper
• Metastatic disease to the liver: Locoregional therapy strategies and outcomes

  2021cites this paper
• Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma

  2021cites this paper
• The role of functional imaging; DWI, ADC and 18F-FDG PET/CT in the evaluation of HCC treatment response after transarterial chemoembolization

  2021cites this paper
• Imaging After Locoregional Therapy for Hepatocellular Carcinoma with Emphasis on LIRADS Treatment Response Assessment Criteria.

  2021cites this paper
• Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy

  2021cites this paper
• Cost-Effectiveness of Imaging Tumor Response Criteria in Hepatocellular Cancer After Transarterial Chemoembolization.

  2021cites this paper
• An observational study to justify and plan a future phase III randomized controlled trial of metformin in improving overall survival in patients with inoperable pancreatic cancer without liver metastases

  2020cites this paper
• Microwave Ablation and/or Transcatheter Arterial Chemo-embolization in the Treatment of Hepatocellular Carcinoma

  2020cites this paper
• Hepatic tumors: pitfalls in diagnostic imaging

  2020cites this paper
• Three-Dimensional Neural Network to Automatically Assess Liver Tumor Burden Change on Consecutive Liver MRIs.

  2020cites this paper
• Radio-Pathological Correlations in Patients with Liver Metastases for Colorectal Cancer

  2020cites this paper
• Therapy Response Imaging in Hepatobiliary and Pancreatic Malignancies

  2020cites this paper
• Current state of the art imaging approaches for colorectal liver metastasis.

  2020cites this paper
• Comparison of Response and Outcomes of Drug-eluting Bead Chemoembolization (DEB-TACE) Versus Radioembolization (TARE) for Patients With Colorectal Cancer Liver Metastases

  2019cites this paper
• Assessment of the response of hepatocellular carcinoma to interventional radiology treatments.

  2019cites this paper
• Assessment of Radioembolization Treatment Response: Standardization, Tips & Tricks

  2019cites this paper
• Tumor Response Criteria in Oncoimaging: RECIST Criteria and beyond—Part 1

  2019cites this paper
• Identifying Quantitative Enhancement-Based Imaging Biomarkers In Patients With Colorectal Cancer Liver Metastases Undergoing Loco-Regional Tumor Therapy

  2019cites this paper
• Tumor Response Criteria in Oncoimaging: RECIST Criteria and beyond—Part 2

  2019cites this paper
• МЕТАСТАЗЫ КОЛОРЕКТАЛЬНОГО РАКА В ПЕЧЕНЬ ПОСЛЕ ХИМИОЭМБОЛИЗАЦИИ МИКРОСФЕРАМИ: ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ ЛУЧЕВЫХ ПРИЗНАКОВ ОЧАГОВ И ВЫБОР КРИТЕРИЕВ ОЦЕНКИ ОБЪЕКТИВНОГО ОТВЕТА

  2018cites this paper
• COLORECTAL LIVER METASTASES AFTER CHEMOEMBOLIZATION WITH MICROSPHERES: PROGNOSTIC VALUE OF LESION FEATURES AND CHOICE OF THE OBJECTIVE RESPONSE CRITERIA

  2018cites this paper
• Recent advances in non-invasive magnetic resonance imaging assessment of hepatocellular carcinoma

  2018cites this paper
• Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?

  2018cites this paper
• Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review

  2018cites this paper
• Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings

  2018cites this paper
• Quantitative image analysis for evaluation of tumor response in clinical oncology

  2018cites this paper
• Evaluation of hepatocellular carcinoma transarterial chemoembolization using quantitative analysis of 2D and 3D real-time contrast enhanced ultrasound

  2018cites this paper
• Assessment of Therapy Response to Transarterial Radioembolization for Liver Metastases by Means of Post-treatment MRI-Based Texture Analysis

  2018cites this paper
• Radiogenomics of hepatocellular carcinoma: multiregion analysis-based identification of prognostic imaging biomarkers by integrating gene data—a preliminary study

  2018cites this paper
• Computed Tomography Advances in Oncoimaging.

  2018cites this paper
• A Software for Quantitative Liver DCE and DWI-MRI to Support Treatment Monitoring in Liver Cancer and Metastasis

  2018cites this paper
• Targeted radiotherapy in metastatic neuroendocrine tumours: clinical and experimental studies

  2018influential citation
• Imaging evaluation of sorafenib for treatment of advanced hepatocellular carcinoma.

  2018cites this paper
• Overview and definitions on lung cancer diagnosis

  2018cites this paper
• Choice of Intra-arterial Therapy for Hepatocellular Carcinoma: Evidence and Future Horizons

  2017cites this paper
• The effects of iterative reconstruction in CT on low-contrast liver lesion volumetry: a phantom study

  2017cites this paper
• Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis

  2017cites this paper
• Computed Tomography Assessment of Hepatic Metastases of Breast Cancer with Revised Response Evaluation Criteria in Solid Tumors (RECIST) Criteria (Version 1.1): Inter-Observer Agreement

  2017cites this paper
• Functional Imaging and Assessment of Antitumor Activity in Systemic Therapy for Hepatocellular Carcinoma

  2017cites this paper
• Thermal ablation may improve outcomes in patients with colorectal liver metastasis: a case-control study.

  2017cites this paper
• New concepts in embolotherapy of HCC

  2017cites this paper
• Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?

  2017cites this paper
• 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.

  2017cites this paper
• Adoption of Splenic Enhancement to Time and Trigger the Late Hepatic Arterial Phase During MDCT of the Liver: Proof of Concept and Clinical Feasibility.

  2016cites this paper
• Diffusion weighted and dynamic contrast enhanced magnetic resonance imaging in assessment of malignant liver tumors after percutaneous radiofrequency ablation

  2016cites this paper
• The role of interventional radiology in the treatment of intrahepatic cholangiocarcinoma

  2016cites this paper
• Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.

  2016cites this paper
• Volumetry of low-contrast liver lesions with CT: Investigation of estimation uncertainties in a phantom study.

  2016cites this paper
• Current Guidelines for the Diagnosis and Management of Hepatocellular Carcinoma: A Comparative Review.

  2016cites this paper
• Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration

  2016cites this paper
• Renal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis

  2016cites this paper
• Hypo-Vascular Liver Metastases Treated with Transarterial chemoembolization: Assessment of Early Response by Volumetric Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance Imaging1

  2016cites this paper
• Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions.

  2015cites this paper
• Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survival.

  2015cites this paper
• МЕТАСТАЗЫ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ В ПЕЧЕНЬ ПОСЛЕ ЛЕЧЕНИЯ МЕТОДОМ ХИМИОЭМБОЛИЗАЦИИ ПЕЧЕНОЧНОЙ АРТЕРИИ: КИНЕТИКА РОСТА ПЕЧЕНОЧНЫХ ОЧАГОВ

  2015cites this paper
• Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma.

  2015cites this paper
• Performance of tumor growth kinetics as an imaging biomarker for response assessment in colorectal liver metastases: correlation with FDG PET

  2015cites this paper
• Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis

  2015cites this paper
• ВЛИЯНИЕ УСЛОВИЙ ТРУДА МЕДИЦИНСКИХ РАБОТНИКОВ НА ИХ СТОМАТОЛОГИЧЕСКИЙ СТАТУС

  2015cites this paper
• Imaging of the Liver Following Interventional Therapy for Hepatic Neoplasms.

  2015cites this paper
• Is CT perfusion ready for liver cancer treatment evaluation?

  2015cites this paper
• Invited Commentary: (90)Y Radioembolization.

  2015cites this paper
• Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging Markers.

  2015cites this paper
• Hepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastases.

  2015cites this paper
• Feasibility of Using Volumetric Contrast-Enhanced Ultrasound with a 3-D Transducer to Evaluate Therapeutic Response after Targeted Therapy in Rabbit Hepatic VX2 Carcinoma.

  2015cites this paper
• Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.

  2015cites this paper
• RECENT ADVANCES IN IMAGE PROCESSING TECHNIQUES USING USG AND MRI OF LIVER

  2015cites this paper
• Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver

  2015cites this paper
• Correlación radio-patológica de criterios morfológicos en la valoración de metástasis hepáticas de adenocarcinoma de colon

  2014cites this paper
• Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.

  2014cites this paper
• Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma and the Evaluation of Response to Treatment

  2014cites this paper
• Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization1

  2014influential citation
• Tumor growth kinetics versus RECIST to assess response to locoregional therapy in breast cancer liver metastases.

  2014cites this paper
• Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.

  2014cites this paper
• CT perfusion in oncologic imaging: a useful tool?

  2013cites this paper